New guidance on the role of RAS and BRAF mutations in MSI-high and dMMR metastatic colorectal cancer. (Oncodaily)
RAS and BRAF status in MSI-H/dMMR metastatic CRC
The CRC Digest
The CRC Digest
New guidance on the role of RAS and BRAF mutations in MSI-high and dMMR metastatic colorectal cancer. (Oncodaily)